Cascade Pharma

Shanghai, China · Founded 2017 · Privately Held (backing)

Developer of nuclear receptor drugs intended to provide new therapies for chronic liver diseases. Cascade Pharma is based in Shanghai, China and was founded in 2017. It has raised $218 million.

Last price · $/share

—

Implied valuation

—

Total raised

$217.6M

Last round

—

How much has Cascade Pharma raised?

$217.6Macross 0 recorded rounds

Free account

More of Cascade Pharma with a free account

·The complete investor list: 24 names
·Watch Cascade Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Cascade Pharma investors

24 investors are on record for Cascade Pharma, including Puhua Capital, Lapam Capital, CAS Investment Management and Shanghai Pudong Venture Capital.

For fundraisers

Raising for a company like Cascade Pharma?

24 investors have backed Cascade Pharma.

See all 24 investors →

Frequently asked about Cascade Pharma

How much has Cascade Pharma raised?: Cascade Pharma has raised $217.6M in total across 0 recorded funding rounds.